{
    "clinical_study": {
        "@rank": "127781", 
        "arm_group": [
            {
                "arm_group_label": "Genetic High Risk", 
                "description": "None"
            }, 
            {
                "arm_group_label": "Healthy Control"
            }
        ], 
        "biospec_descr": {
            "textblock": "5-10mL of adipose cells in tumescent solution\n\n      5-10mL of venous blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This study aims at finding endophenotypes of schizophrenia at neuronal level by obtaining\n      stem cells which is derived from adipose cells of subjects with heavy genetic loading for\n      schizophrenia then differentiating them into neuronal cells."
        }, 
        "brief_title": "Stem Cell Research on Subjects at Genetic High Risk for Schizophrenia", 
        "condition": "Genetic High Risk for Schizophrenia", 
        "condition_browse": {
            "mesh_term": "Schizophrenia"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        [Subjects at genetic high risk for schizophrenia]\n\n          -  Healthy without any Axis I mental disorder\n\n          -  Is a monozygotic twin of a patient with schizophrenia OR Has at least two family\n             members of schizophrenia in the pedigree, including at least one 1st-degree family\n             member\n\n        [Healthy Control]\n\n          -  Healthy without any Axis I mental disorder\n\n          -  No family members of schizophrenia in the pedigree to the 3rd degree\n\n        Exclusion Criteria:\n\n          -  Significant neurological or medical illness\n\n          -  Psychotic symptoms\n\n          -  Substance abuse\n\n          -  Suicidal risk\n\n          -  Blindness or hearing loss\n\n          -  Taking aspirin, warfarin or hormonal agents\n\n          -  Pregnancy or lactation\n\n          -  Susceptibility for keloid formation\n\n          -  Allergy to lidocaine\n\n          -  History of significant head trauma or loss of consciousness\n\n          -  Mental retardation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "20 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "-  Subjects at genetic high risk for schizophrenia\n\n          -  Healthy control"
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01943175", 
            "org_study_id": "H-1207-117-419", 
            "secondary_id": "A120476"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "schizophrenia", 
            "stem cells", 
            "neurons", 
            "genetic hish risk for schizophrenia"
        ], 
        "lastchanged_date": "December 4, 2013", 
        "location": {
            "contact": {
                "email": "mwchon@gmail.com", 
                "last_name": "Myongwuk Chon, M.D", 
                "phone": "+82-10-7641-5085"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul National University Hospital"
            }, 
            "investigator": {
                "last_name": "Jun Soo Kwon, M.D, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "2", 
        "official_title": "Stem Cell-based Approaches to Neuronal Characteristics and Endophenotype of Schizophrenia in Genetic High Risk Subjects", 
        "overall_contact": {
            "email": "kwonjs@snu.ac.kr", 
            "last_name": "Jun Soo Kwon, M.D, Ph.D", 
            "phone": "+82-2-2072-2450"
        }, 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Jun Soo Kwon, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "in vitro measurement of the expression of the neuronal markers for differentiated post-mitotic neuron, GABAergic/Glutamatergic neuron.\nThe  neuronal connectivity, neurites from soma and synaptic protein levels will be assessed. In addition, RNA and proteins expression (e.g. Glutamate/GABA receptors) , physiological function, and in vitro response to antipsychotics will be evaluated.", 
            "measure": "Structural and functional characteristics of neurons differentiated from adipose tissue derived stem cells in subjects with genetic high risk for schizophrenia and healthy controls", 
            "safety_issue": "No", 
            "time_frame": "three years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01943175"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Clinical rating scale for prodromal symptoms of psychosis.", 
                "measure": "CAARMS(Comprehensive assessment of at risk mental states)", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "Clinical rating scale for the assessment of symptoms of schizophrenia.", 
                "measure": "PANSS(Positive and Negative Syndrome Scale)", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "Neurocognitive function battery comprising tests measuring subjects' intelligence, attention, memory, executive function and social cognitive function.", 
                "measure": "Neurocognitive function test battery (composite)", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "ERP profile including P50, P30 & MMN(Mismatch Negativity).", 
                "measure": "ERP(event-related potential) profile", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "Structural/resting functional MRI data", 
                "measure": "Structural/resting functional MRI data", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "Molecular neuroimaging data measuring neurochemical composition profile.", 
                "measure": "Proton MR spectroscopy", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "PET imaging data measuring receptor availability of GABA(gamma-aminobutyric acid) and Glutamate.", 
                "measure": "PET imaging data", 
                "safety_issue": "No", 
                "time_frame": "Baseline"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Ministry of Health & Welfare, Korea", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Observational Model: Case Control, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}